| |
|
|
|
Neos Therapeutics Inc.  
|
|
0.764 -0.022 (-0.03%) |
01-15 16:00 |
|
Open: |
0.77 |
Pre close: |
0.7856 |
Target:
|
1.14 
|
|
High: |
0.7989 |
Low: |
0.76 |
Resistance:
|
0.97
1.20
|
|
Volume: |
1,811,505 |
Market Cap: |
38M |
Support:
|
0.61
0.51
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.78
|
MACD |
MACD(12,26):
|
0.04 |
|
MA(20): |
0.70 |
Signal(12,26,9): |
0.03 |
|
MA(100): |
0.64 |
Stochastic Oscillator |
%K(14,3):
|
67.35  |
|
MA(250): |
0.83 |
%D(3): |
74.74 |
|
Average Volume(K) |
3-Month: |
477852
|
52-Week |
High:
|
1.98 |
|
10-Days: |
344969 |
Low: |
0.45 |
|
RSI |
RSI(14):
|
59.55 |
Change(%): |
-52.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.439 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
49.76 |
|
EPS Est. Current Year |
-3.110 |
Return on Assets (ttm) |
-10.7 |
Shares Float (M) |
40.23 |
|
EPS Est. Next Year |
-1.440 |
PEG Ratio |
0.00 |
% Held by Insiders |
1.50 |
|
EPS Est. Next Quarter |
-0.670 |
Qtrly Rev. Growth |
-28.5 |
% Held by Institutions |
33.38 |
|
Forward EPS |
-0.340 |
Gross Profit (p.s.) |
0.794 |
Shares Short (K) |
1150 |
|
Book Value (p.s.) |
-0.410 |
EBITDA (p.s.) |
-0.195 |
P/E |
-1.74 |
|
Sales Per Share |
1.145 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-1.86 |
|
Profit Margin |
-38.35 |
Operating Cash Flow
(M) |
-6.41 |
P/S |
0.67 |
|
Operating Margin |
-23.50 |
Levered Free Cash Flow
(M) |
0.81 |
P/CF |
-5.93 |
|
|
|
|
|
|
